Somewhere in England this week, a patient will collect a repeat prescription for a drug they stopped taking months ago, add it to a cupboard already crowded with identical boxes, and never open it. Multiply that scene across the country and the National Pharmacy Association's latest estimate becomes almost plausible: 3,400 tonnes of partly used medicine disposed of in a single year, enough to fill 75 swimming pools, costing the NHS at least £480m. The figure has circulated as a story about waste, framed by pharmacists urging patients to order only what they need. It is worthy of a more difficult reading than that.
The same month this data emerged, health leaders were still describing some of the most serious NHS medicine shortages on record, hormone replacement therapy, epilepsy drugs, common painkillers among them. Estradot and Creon, used respectively by menopausal women and by patients managing pancreatic cancer or cystic fibrosis, have been affected by supply problems serious enough to draw joint warnings from the NPA and the Royal College of GPs. A health system that cannot reliably keep a menopausal woman supplied with her HRT is, in the same reporting period, disposing of enough unused stock to fund thousands of additional appointments. That is not a coincidence of timing. It describes a supply chain with virtually no functional feedback loop connecting what is prescribed, what is consumed, and what is created or purchased next.
NHS England's response points to progress on the NHS app, which now lets patients manage repeat prescriptions from their phones. This is real, and worth acknowledging, but it solves the wrong end of the problem. Making it easier to order a repeat prescription does nothing to flag that the previous three months' supply is sitting untouched in a drawer. The infrastructure exists to track ordering; it does not meaningfully exist to track use, adherence, or redundancy, and until it does, digitising the request form only makes it faster to generate waste rather than slower.
Olivier Picard, the NPA's chair, has called for more frequent medication reviews for patients on multiple repeat items, and that is a sound clinical recommendation on its own terms. But it also quietly concedes the scale of the problem: reviews conducted by already stretched GP practices and community pharmacists are being asked to substitute for a data system that should be doing this work continuously and automatically.As pointed out by Dr. Rasha Abdelsalam Elshenawy from the University of Hertfordshire, one of the more significant long-term risks to the health sector is antimicrobial resistance, which is fuelled by leftover antibiotics maintained at home and later used without medical supervision. It has clinical consequences that compound over years rather than showing up in a single financial cycle.
This should be important to a government preparing for an autumn budget that is already influenced by competing claims on health expenditure and little budgetary space. £480m is not a marginal figure against the pressures facing NHS finances, and ministers preparing to defend departmental settlements will find it a difficult number to explain away as simply a matter of patient behaviour. It also sits awkwardly against a wider prevention and productivity agenda that has talked for years about medicines optimisation without building the underlying data architecture to make it real. Repeat prescribing was digitised because it was operationally convenient to digitise. Medicines management, the harder and more clinically consequential problem, was left for pharmacists to manage through conversation and goodwill.
None of this requires dramatic intervention to begin addressing. Prescribing systems already hold the data needed to flag patients whose repeat orders have gone unused for consecutive cycles; the gap is in acting on it systematically rather than through occasional review. What the NPA's figures actually expose is a health service that has automated the parts of medicines management that were easy and left the parts that require judgement to chance. Until that changes, the waste and the shortages will keep arriving in the same news cycle, each treated as a separate story, when they are in fact the same one.
